Sign up
Quantellect · Congress · Trade Detail
TKPYYTakeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund
RepublicanHouse

Greg Gianforte sold Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY)

Greg Gianforte (R-MT), a U.S. Representative, has disclosed 1 trade in Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY) since 2018, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Greg Gianforte sold $1,001 - $15,000 of Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY) on November 19, 2018. Since that trade, TKPYY is up +0.00% against the S&P 500 up +209.11%, an outperformance of -209.11%.

Data updated

TKPYY trades
1
Disclosed Vol
$8K
Buys
0
0%
Sells
1
100%
Buy / Sell
0.00
ratio
First → Last
2018

Greg Gianforte's TKPYY trades vs the price

TKPYY is up +0.00% since Greg Gianforte sold on November 19, 2018, versus +209.11% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+209.11%
Outperformance vs S&P 500
-209.11%

All Greg Gianforte TKPYY trades

TradedTypeSizeReturnEst. profit
November 19, 2018SELL$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Greg Gianforte & TKPYY trading FAQ

Is it legal for Greg Gianforte to trade Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Greg Gianforte sell TKPYY?

Greg Gianforte disclosed a sale of $1,001 - $15,000 of Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY) on November 19, 2018, according to public STOCK Act filings.

How has TKPYY performed since Greg Gianforte's trade?

Since Greg Gianforte sold TKPYY on November 19, 2018, the stock is up +0.00%, versus +209.11% for the S&P 500 over the same period, an outperformance of -209.11%.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional TKPYY trades?

Quantellect tracks every disclosed congressional trade in Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund (TKPYY) on the Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity Fund congressional trading page, which aggregates filings across all members of Congress.

Greg Gianforte's TKPYY tradesAll congressional filings for Takeda Pharmaceutical Co Ltd Sponsored AdR (TKPYY) [ST] F ILING S TATUS : New S UbHOLdING O F : TWP Parametric Core Int'l Equity FundGreg Gianforte's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.